You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
瑞聯新材(688550.SH):終止原料藥項目

格隆匯7月28日丨瑞聯新材(688550.SH)公佈,公司於2025年7月28日召開第三屆董事會2025年第二次臨時會議、第三屆監事會2025年第二次臨時會議,審議通過了《關於終止部分募集資金投資項目的議案》,同意公司終止渭南瑞聯製藥有限責任公司原料藥項目(以下簡稱“原料藥項目”),截至2025年6月30日,原料藥項目累計投入募集資金17,869.99萬元,項目已簽訂合同待支付尾款金額共計611.07萬元,剩餘募集資金21,569.37萬元(包含募集資金利息收入及理財收益)仍將存放於原募集資金專用賬戶並按照公司相關管理規定做好募集資金管理。未來公司將盡快尋找盈利能力較強且有發展前景的新項目,合理使用剩餘的募集資金,並嚴格按照募集資金使用的監管要求履行相關審議程序並及時披露,以保證募集資金的安全和有效利用。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account